dc.contributor.author | Carlos Sanchez-Piedra | |
dc.contributor.author | Cesar Diaz-Torne | |
dc.contributor.author | Javier Manero | |
dc.contributor.author | José M Pego-Reigosa | |
dc.contributor.author | Íñigo Rúa-Figueroa | |
dc.contributor.author | González-Gay Mantecón, Miguel Ángel | |
dc.contributor.author | Juan Gomez-Reino | |
dc.contributor.author | Jose M Alvaro-Gracia | |
dc.contributor.other | Universidad de Cantabria | es_ES |
dc.date.accessioned | 2021-04-15T10:05:28Z | |
dc.date.available | 2021-04-15T10:05:28Z | |
dc.date.issued | 2020 | |
dc.identifier.issn | 0003-4967 | |
dc.identifier.issn | 1468-2060 | |
dc.identifier.uri | http://hdl.handle.net/10902/21237 | |
dc.format.extent | 3 p. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | BMJ Publishing Group | es_ES |
dc.rights | Attribution 4.0 International © Author(s) (or their employer(s)) 2020 | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.source | Annals of the Rheumatic Diseases July 2020 Vol 79 No 7 | es_ES |
dc.title | Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
dc.relation.publisherVersion | http://dx.doi.org/10.1136/annrheumdis-2020-217948 | es_ES |
dc.rights.accessRights | openAccess | es_ES |
dc.identifier.DOI | 10.1136/annrheumdis-2020-217948 | |
dc.type.version | publishedVersion | es_ES |